UNH's fourth-quarter earnings are likely to have benefited from growing premiums and service revenues.
As UnitedHealth Group executives mourn the death of one of their top executives, the nation's biggest health insurance company is bracing for this week's reaction to another multi-billion-dollar profit for the fourth quarter.
UnitedHealth (UNH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
UnitedHealth Group Incorporated's Q4 results are expected to surface on January 16th, with analysts expecting revenue to settle at $101.76 billion and EPS at $6.26. In our view, UnitedHealthcare's sustainable growth and Optum's robust performance, especially in Optum Health and Optum Rx, suggest continued top-line growth and potential for higher profit margins. UnitedHealth's valuation metrics indicate a potential buy-the-dip opportunity, with forward ratios mostly below their five-year averages and a promising dividend profile.
UnitedHealth Group Incorporated UNH will release earnings results for its fourth quarter, before the opening bell on Thursday, Jan. 16, 2025.
UNH and AMED are now expected to identify new buyers for the divestment assets by March 2025.
UnitedHealth (UNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth Group shareholders on Wednesday said they requested the company prepare a report on the costs and public health impact related to its "practices that limit or delay access to healthcare."
The Investment Committee give you their top stocks to watch for the second half.
UnitedHealth Group (UNH) closed the most recent trading day at $513.67, moving +0.13% from the previous trading session.
Shares of UnitedHealth Group (UNH 1.83%) were pulling back in December due to a backlash against the company following the murder of one of its executives and reports of a potential crackdown on pharmacy benefit managers (PBMs), including UnitedHealth's OptumRx.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.